Oxford and Liverpool scientists launch new vaccine trial for Middle East Respiratory Syndrome (MERS)

Published on September 18, 2023

A new clinical trial to find a vaccine to protect people against Middle East Respiratory Syndrome (MERS) launched last week (Friday 15 September 2023).  This is the third Phase I clinical trial of the ChAdOx1 MERS vaccine, developed by researchers at the University of Oxford’s Pandemic Sciences Institute. It is the first trial in older people.
Continue reading on website
Other news

Oxford ranked third most intensive science and innovation cluster in the world

September 18, 2023
Oxford has been recognised as one of the top science and innovation clusters in the world, according to new data released today from the upcoming 2023 Global Innovation Index (GII).

Foundation Ceremony: Performances mark construction progress for the Schwarzman Centre

September 19, 2023
Spoken word poetry, song and parkour performances took place on and around the building site for the Stephen A. Schwarzman Centre for the Humanities this week, as Oxford University held a foundation ceremony to mark two years until the building is completed.